Company Information

Company UCB Pharma SpA
Pharmaceuticals & Biotechnology
Publicly Listed
Global Compact Status:
Participant Since
14 June 2021
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2024

Parent Company

Country Company Name
Belgium UCB SA/NV

Communication On Progress

Published On Title Level/Status
02-May-2022 UCB Integrated Annual Report 2021 Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.

Parent Communication On Progress

Published On Title Level/Status
03-Mar-2022 UCB Integrated Annual report Active
29-Nov-2021 Grace Letter Not applicable